Evaluation of gastroprotectant administration in hospitalized cats in a tertiary referral hospital
- PMID: 37874311
- PMCID: PMC10812023
- DOI: 10.1177/1098612X231201769
Evaluation of gastroprotectant administration in hospitalized cats in a tertiary referral hospital
Abstract
Objectives: The primary objective of this study was to evaluate the prescription patterns and appropriateness of the use of gastroprotectant medication in cats.
Methods: Pharmacy dispensation logs from an academic tertiary referral center were reviewed between 1 January 2018 and 31 December 2018. Cats that were administered proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), sucralfate, misoprostol, antacids or a combination were included. Data regarding medication, dosage, formulation, duration of administration, completeness of discharge instructions and clinical rationales for administration were obtained from medical records. The appropriateness of gastroprotectant use was assessed according to the American College of Veterinary Internal Medicine consensus statement guidelines.
Results: Of the 110 cases, 67 (60.9%) were prescribed a gastroprotectant medication without an appropriate indication. The most common reason for prescription was acute kidney injury in 26/67 (38.8%). PPIs were the most common gastroprotectant medication administered in 95/110 (86.3%) cats, followed by sucralfate in 18/110 (16.4%) and H2RAs in 11/110 (10%). Of the 35 cases in which gastroprotectant therapy was indicated, the medication chosen or dosage administered was considered suboptimal in 16 (45.7%). Instructions regarding the duration of administration, potential adverse effects and timing of administration in relation to meals or other medications were inconsistently provided in discharge instructions to pet owners. Of the 29 cases discharged with omeprazole, only 13 (44.8%) instructions included a duration of administration, while 6 (20.7%) recommended continuing gastroprotectants indefinitely until further notice, 16 (55.2%) discussed the timing of the administration in relation to a meal and six (20.7%) mentioned potential adverse effects; none advised tapering of omeprazole before discontinuation.
Conclusions and relevance: When prescribed, gastroprotectant medications were frequently prescribed injudiciously to cats in this referral population over a 12-month period. Discharge instructions to pet owners also often lacked information and recommendations regarding optimal administration, potential adverse effects, and tapering or discontinuation of the medications.
Keywords: Acid suppressant; erosion; famotidine; gastrointestinal ulcer; histamine-2 receptor antagonist; omeprazole, pantoprazole; proton pump inhibitor; sucralfate.
Conflict of interest statement
Conflict of interestThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Prevalence and appropriateness of omeprazole prescription in dogs at a veterinary teaching hospital before and after the publication of the ACVIM consensus statement on the rational administration of gastrointestinal protectants.Front Vet Sci. 2024 May 7;11:1352496. doi: 10.3389/fvets.2024.1352496. eCollection 2024. Front Vet Sci. 2024. PMID: 38774912 Free PMC article.
-
Evaluation of proton pump inhibitor administration in hospitalized dogs in a tertiary referral hospital.J Vet Intern Med. 2022 Sep;36(5):1622-1627. doi: 10.1111/jvim.16491. Epub 2022 Jul 22. J Vet Intern Med. 2022. PMID: 35866265 Free PMC article.
-
Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.J Manag Care Pharm. 2009 May;15(4):344-50. doi: 10.18553/jmcp.2009.15.4.344. J Manag Care Pharm. 2009. PMID: 19422274 Free PMC article.
-
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.Clin Pharmacokinet. 1996 Nov;31(5):386-406. doi: 10.2165/00003088-199631050-00005. Clin Pharmacokinet. 1996. PMID: 9118586 Review.
-
Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD011785. doi: 10.1002/14651858.CD011785.pub2. Cochrane Database Syst Rev. 2019. PMID: 31265739 Free PMC article.
Cited by
-
Retrospective evaluation of the effect of acid suppressant drugs on leukocyte ratios in dogs with mast cell tumors.J Vet Intern Med. 2024 Jul-Aug;38(4):2305-2315. doi: 10.1111/jvim.17133. Epub 2024 Jun 18. J Vet Intern Med. 2024. PMID: 38888250 Free PMC article.
-
Prevalence and appropriateness of omeprazole prescription in dogs at a veterinary teaching hospital before and after the publication of the ACVIM consensus statement on the rational administration of gastrointestinal protectants.Front Vet Sci. 2024 May 7;11:1352496. doi: 10.3389/fvets.2024.1352496. eCollection 2024. Front Vet Sci. 2024. PMID: 38774912 Free PMC article.
-
Rational use of gastroprotectants in cats: An evidence-based approach.J Feline Med Surg. 2024 Aug;26(8):1098612X241274235. doi: 10.1177/1098612X241274235. J Feline Med Surg. 2024. PMID: 39105658 Free PMC article. Review.
References
-
- Heidelbaugh JJ, Goldberg KL, Inadomi JM. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 2010; 16: e228–234. - PubMed
-
- Herszényi L, Bakucz T, Barabás L, et al.. Pharmacological approach to gastric acid suppression: past, present, and future. Dig Dis 2020; 38: 104–111. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous